Inovio Pharmaceuticals (INO) EBITDA (2010 - 2026)
Inovio Pharmaceuticals (INO) posted EBITDA of -$18.3 million for Q2 2026, compared with -$22.73 million a year earlier.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Inovio Pharmaceuticals was -$77.93 million; for FY2025, it came in at -$85.4 million.
- In prior years, Inovio Pharmaceuticals' EBITDA was -$110.6 million in FY2024, -$141.17 million in FY2023, -$263.38 million in FY2022 and -$297.66 million in FY2021.
- Quarterly EBITDA has run from a low of -$104.44 million in Q4 2021 to a high of -$17.14 million in Q4 2025 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$21.63 million (Q1 2026), -$17.14 million (Q4 2025) and -$20.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - | -18.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.30 Mn |
| Mar 31, 2026 | -21.63 Mn |
| Dec 31, 2025 | -17.14 Mn |
| Sep 30, 2025 | -20.86 Mn |
| Jun 30, 2025 | -22.73 Mn |
| Mar 31, 2025 | -24.68 Mn |
| Dec 31, 2024 | -19.90 Mn |
| Sep 30, 2024 | -26.93 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Mar 31, 2024 | -31.06 Mn |
| Dec 31, 2023 | -26.82 Mn |
| Sep 30, 2023 | -34.91 Mn |
| Jun 30, 2023 | -36.27 Mn |
| Mar 31, 2023 | -43.16 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -34.73 Mn |
| Jun 30, 2022 | -103.07 Mn |
| Mar 31, 2022 | -70.68 Mn |
| Dec 31, 2021 | -104.44 Mn |
| Sep 30, 2021 | -59.09 Mn |
API Access
Inovio Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();